Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Patent
1999-06-08
2000-05-09
Brusca, John S.
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
4353201, C12N 1585, C12N 1563
Patent
active
06060316&
ABSTRACT:
Novel targeting methods of viral entry are disclosed herein.
REFERENCES:
Snitkovsky S. and Young J.A., "Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein," Proc. Natl. Acad. Sci U.S.A., 9512);7063-7068 (Jun. 9, 1998).
Damico, R.L. et al., "Receptor-triggered membrane association of a model retroviral glycoprotein," Proc. Natl. Acad. Sci. U.S.A., 95(5):2580-2585 (Mar. 3, 1998).
Hernandez, L.D. et al., "Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein," J. Cell Biol., 139(6):1455-1464 (Dec. 15, 1997).
Etienne-Julan, M. et al., "The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker," J. of General Virology, 73:3251-3255 (1992).
Kasahara, N. et al., "Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor Interactions," Science, 266:1373-1376 (Nov. 25, 1994).
Kasahara, N. et al., "Tissue-specific targeting of retroviral vectors via ligand-receptor interactions," Advanced Drug Delivery Reviews, 17:227-234 (1995).
Han, X. et al., "Ligand-directed retroviral targeting of human breast cancer cells," Proc. Natl. Acad. Sci. USA, 92:9747-9751 (Oct. 1995).
Cosset, F.L. and Russell, S.J., "Targeting retrovirus entry," Gene Therapy, 3:946-956 (1996).
Chu, T.H.T., and Dornburg, R., "Toward Highly Efficient Cell-Type-Specific Gene Transfer with Retroviral Vectors Displaying Single-Chain Antibodies," J. of Virology, 71:720-725 (Jan. 1997).
Valsesia-Wittmann, S. et al., "Modifications in the Binding Domain of Avian Retrovirus Envelope Protein To Redirect the Host Range of Retroviral Vectors," J. of Virology, 68:4609-4619 (Jul. 1994).
Somia, N.V., et al., "Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery," Proc. Natl. Acad. Sci. U.S.A., 92:7570-7574 (Aug. 1995).
Roux, P. et al., "A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibiligy complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses," Proc. Natl. Acad. Sci. U.S.A., 86:9079-9083 (Dec. 1989).
Davey, R.A. et al., "In Vitro Binding of Purified Murine Ecotropic Retrovirus Envelope Surface Protein to Its Receptor, MCAT-1," J. of Virology, 71:8096-8102 (Nov. 1997).
Matano, T. et al., "Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1," J. of General Virology, 76:3165-3169 (1995).
Cosset, F.L. et al., "Retroviral Retargeting by Envelopes Expressing an N-Terminal Binding Domain," J. of Virology, 69:6314-6322 (Oct. 1995).
Ager, S. et al., "Retroviral Display of Antibody Fragments; Interdomain Spacing Strongly Influences Vector Infectivity," Human Gene Therapy, 7:2157-2164 (Nov. 10, 1996).
Valsesia-Wittman, S. et al., "Improvement of Retroviral Retargeting by Using Amino Acid Spacers between an Additional Binding Domain and the N Terminus of Moloney Murine Leukemia Virus Su," J. of Virology, 70(3):2059-2064 (Mar. 1996).
Marin, M. et al., "Targeted Infection of Human Cells via Major Histocompatibility Complex Class I Molecules by Moloney Murine Leukemia Virus-Derived Viruses Displaying Single-Chain Antibody Fragment-Envelope Fusion Proteins," J. of Virology, 70(5):2957-2962 (May 1996).
Neda, H. et al., "Chemical Modification of an Ecotropic Murine Leukemia Virus Results in Redirection of Its Target Cell Specificity," The Journal of Biological Chemistry, 266(22):14143-14146 (Aug. 5, 1991).
Nilson, B.H.K. et al., "Targeting of retroviral vectors through protease-substrate interactions," Gene Therapy, 3:280-286 (1996).
Chu, T.H.T. et al., "Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins," Gene Therapy, 1:292-299 (1994).
Martin, F. et al., "Retroviral Vector Targeting to Melanoma Cells by Single-Chain Antibody Incorporation in Envelope," Human Gene Therapy, 9:737-746 (Mar. 20, 1998).
Valsesia-Wittmann, S. et al., "Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding," The EMBO Journal, 16(6):1214-1223 (1997).
Fielding, A.K. et al., "Inverse Targeting of Retroviral Vectors: Selective Gene Transfer in a Mixed Population of Hematopoietic and Nonhematopoietic Cells," Blood, 91(5):1802-1809 (Mar. 1, 1998).
Chu, T.H.T. and Dornburg, Ralph, "Retroviral Vector Particles Displaying the Antigen-Binding Site of an Antibody Enable Cell-Type-Specific Gene Transfer," J. of Virology, 69(4):2659-2663 (Apr. 1995).
Michael, S.I. et al., "Strategies to Accomplish Targeted Gene Delivery Employing Tropism-Modified Recombinant Adenoviral Vectors," Cancer Gene Therapy, 2(4):321 (1995), Abstract O-44.
Nilson, B.H.K. et al., "Regulatable Tropism of Retroviral Vectors Displaying a Cleavable Polypeptide Ligand," Cancer Gene Therapy, 2(4):322-323 (1995), Abstract O-51.
Porter, C.D. et al., "Comparison of Efficiency of Infection of Human Gene Therapy Target Cells via Four Different Retroviral Receptors," Human Gene Therapy, 7:913-919 (May 20, 1996).
Peng, K.W. et al., "A Gene Delivery System Activatable by Disease-Associated Matrix Metalloproteinases," Human Gene Therapy, 8:729-738 (Apr. 10, 1997).
Goud, B. et al., "Antibody-Mediated Binding of a Murine Ecotropic Moloney Retroviral Vector to Human Cells Allows Internalization But Not the Establishment of the Proviral State," Virology, 163:251-254 (1988).
Russell, S.J. et al., "Retroviral vectors displaying functional antibody fragments," Nucleic Acids Research, 21(5):1081-1085 (1993).
Schnell, M.J. et al., "Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses ae incorporated efficiently into virus particles," Proc. Natl. Acad. Sci. U.S.A., 93:11359-11365 (Oct. 1996).
Mulligan Richard C.
Niederman Thomas M. J.
Snitkovsky Sophie
Young John A. T.
Brusca John S.
President and Fellows of Harvard College
Sandals William
The Children's Medical Center Corp.
LandOfFree
Methods of targeting of viral entry does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of targeting of viral entry, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of targeting of viral entry will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1064075